UK markets closed

Clinigen Group plc (CGNGY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
13.250.00 (0.00%)
At close: 9:32AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 31.22B
Trailing P/E 21.58
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)1.97
Enterprise value/revenue 32.32
Enterprise value/EBITDA 711.28

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-38.37%
S&P500 52-week change 336.35%
52-week high 321.50
52-week low 39.15
50-day moving average 313.25
200-day moving average 313.25

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 60.32M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.08
Trailing annual dividend yield 30.57%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 330 Apr 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 29 Jun 2021
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 5.79%
Operating margin (ttm)11.19%

Management effectiveness

Return on assets (ttm)3.32%
Return on equity (ttm)8.90%

Income statement

Revenue (ttm)523.6M
Revenue per share (ttm)7.87
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)197.9M
EBITDA 107.9M
Net income avi to common (ttm)39.7M
Diluted EPS (ttm)0.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)82.9M
Total cash per share (mrq)1.25
Total debt (mrq)418.7M
Total debt/equity (mrq)93.67
Current ratio (mrq)1.75
Book value per share (mrq)6.72

Cash flow statement

Operating cash flow (ttm)45.2M
Levered free cash flow (ttm)-17.45M